- £193.88m
- £167.93m
- £110.67m
- 91
- 45
- 86
- 91
Annual income statement for Science, fiscal year end - December 31st, GBP millions except per share, conversion factor applied.
2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | ARS | ARS | ARS | ARS | ARS |
| Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
| Status: | Final | Final | Final | Final | Final |
| Revenue | |||||
| Total Revenue | 73.7 | 81.2 | 86.3 | 113 | 111 |
| Selling / General / Administrative Expenses | |||||
| Depreciation and Amortization | |||||
| Unusual Expense / Income | |||||
| Other Operating Expenses | |||||
| Total Operating Expenses | 66.5 | 69.6 | 74.6 | 105 | 95.8 |
| Operating Profit | 7.13 | 11.6 | 11.7 | 8.14 | 14.9 |
| Total Net Non Operating Interest Income / Expense | |||||
| Other Net Non Operating Costs | |||||
| Net Income Before Taxes | 6.39 | 10.9 | 11.1 | 7.62 | 14.7 |
| Provision for Income Taxes | |||||
| Net Income After Taxes | 7.04 | 9.56 | 10.6 | 5.52 | 12 |
| Net Income Before Extraordinary Items | |||||
| Net Income | 7.04 | 9.56 | 10.6 | 5.52 | 12 |
| Income Available to Common Shareholders Excluding Extraordinary Items | |||||
| Income Available to Common Shareholders Including Extraordinary Items | |||||
| Dilution Adjustment | |||||
| Diluted Net Income | 7.04 | 9.56 | 10.6 | 5.52 | 12 |
| Diluted Weighted Average Shares | |||||
| Basic EPS Including Extraordinary Items | |||||
| Diluted EPS Including Extraordinary Items | |||||
| Diluted EPS Excluding Extraordinary Items | |||||
| Normalised Income Before Taxes | |||||
| Normalised Income After Taxes | |||||
| Normalised Income Available to Common Shareholders | |||||
| Diluted Normalised EPS | 0.175 | 0.217 | 0.248 | 0.202 | 0.26 |
| Dividends per Share |